webinar register page

Development of Orphan Biologics: Challenges and Opportunities
Webinar sponsored by Catalent

The development of therapies for rare diseases comes with distinct challenges, including patient recruitment, setting meaningful clinical endpoints, manufacturing and supply and finding the regulatory and market pathway to ensure patients can access therapy.
For biologic products (growth factors, monoclonal antibodies, other complex proteins), development and production costs tend to be higher due to the complexity of the drug substance. To manage costs, the clinical development and manufacturing and Chemistry, Manufacturing and Controls (CMC) teams need to be aligned to ensure drug product is delivered on time to meet clinical trial needs.
These challenges sit within a wider regulatory and legislative framework for orphan medicinal products (OMPs) that defines whether companies can successfully develop a novel product to market and thus the decisions made for selecting therapeutics and target diseases early in development.
During this webinar, speakers cover aspects of clinical trial design for orphan biologics products, key strategies for ensuring clinical trial supply throughout clinical development and the regulatory and legislative framework for delivery to patients.

How we will use your data: In registering for this webinar, Europabio will retain your information only for the purposes of webinar delivery and post-webinar follow up with the event recording. Your information will not be shared with any third parties.

Apr 18, 2023 03:00 PM in Brussels

* Required information